Expert Review of Pharmacoeconomics & Outcomes Research, Volume 23, Issue 10 (2023)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 23, Issue 10 (2023)

See all volumes and issues
Vol 24, 2024 Volume 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Time to treat the climate and nature crisis as one indivisible global health emergency
Kamran Abbasi, Parveen Ali, Virginia Barbour, Thomas Benfield, Kirsten Bibbins-Domingo, Gregory E. Erhabor, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Robert Mash, Peush Sahni, Wadeia Mohammad Sharief, Paul Yonga & Chris Zielinski
Pages: 1113-1115
Published online: 30 Oct 2023
First Page PreviewforTime to treat the climate and nature crisis as one indivisible global health emergency | Full Text | References | PDF (155 KB) | EPUB
  • 246 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Assessment of women’s treatment preferences for vasomotor symptoms due to menopause
Aki Shiozawa, Rebecca C. Thurston, Erin Cook, Hongbo Yang, Deanna D. King, Rita M. Kristy & Shayna Mancuso
Pages: 1117-1128
Published online: 31 Aug 2023
AbstractforAssessment of women’s treatment preferences for vasomotor symptoms due to menopause | Full Text | References | PDF (434.5 KB) | EPUB | Supplemental
  • 1578 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-utility analysis of multiple sclerosis rehabilitation in Iran
Rajabali Daroudi, Mirtaher Mousavi, Marzieh Shirazikhah, Mehdi Alizadeh Zarei, Hamidreza Hendi, Faezeh Joghataei & Ali Darvishi
Pages: 1129-1137
Published online: 28 Aug 2023
AbstractforCost-utility analysis of multiple sclerosis rehabilitation in Iran | Full Text | References | PDF (3.4 MB) | EPUB
  • 67 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Cost-effectiveness of somatrogon in the Spanish pediatric population with growth hormone deficiency
M.A. Andreu Crespo, L. Castro-Feijóo, J.I. Labarta-Aizpún, C. Peral, J.A. Barrueta, D. Rubio-Rodríguez & C. Rubio-Terres
Pages: 1139-1146
Published online: 24 Sep 2023
AbstractforCost-effectiveness of somatrogon in the Spanish pediatric population with growth hormone deficiency | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 1126 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Burden of osteoarthritis in the Netherlands: a scoping review
Charlotte Beaudart, Nannan Li, Annelies Boonen & Mickael Hiligsmann
Pages: 1147-1167
Published online: 02 Oct 2023
AbstractforBurden of osteoarthritis in the Netherlands: a scoping review | Full Text | References | PDF (745.8 KB) | EPUB
  • 1088 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Emerging trends: the involvement of community pharmacists in the planning and execution of pharmaceutical policies and economics
Ali Alshahrani
Pages: 1169-1176
Published online: 25 Sep 2023
AbstractforEmerging trends: the involvement of community pharmacists in the planning and execution of pharmaceutical policies and economics | Full Text | References | PDF (1.4 MB) | EPUB
  • 620 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Evaluating high-cost technologies – no need to throw the baby out with the bathwater
Gurdeep S Sagoo, Tomos Robinson, Diarmuid Coughlan, Nick Meader, Stephen Rice & Luke Vale
Pages: 1177-1183
Published online: 28 Sep 2023
AbstractforEvaluating high-cost technologies – no need to throw the baby out with the bathwater | Full Text | References | PDF (261 KB) | EPUB
  • 626 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Inebilizumab for neuromyelitis optica spectrum disorders in Italy: a budget impact model
Carlo Lazzaro, Nicola Amedeo Mazzanti, Silvia Rossi & Fabio Parazzini
Pages: 1185-1200
Published online: 17 Oct 2023
AbstractforInebilizumab for neuromyelitis optica spectrum disorders in Italy: a budget impact model | Full Text | References | PDF (3.1 MB) | EPUB | Supplemental
  • 1177 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Is Palbociclib a cost-effective strategy in the second-line treatment of metastatic breast cancer in Iran?
Ali Darvishi, Ramin Abdi Dezfouli, Aliakbar Fazaeli, Rajabali Daroudi & Narges Zandieh
Pages: 1201-1210
Published online: 28 Sep 2023
AbstractforIs Palbociclib a cost-effective strategy in the second-line treatment of metastatic breast cancer in Iran? | Full Text | References | PDF (2.7 MB) | EPUB
  • 90 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles